BioSyent Inc.
BIOYF
$10.61
-$0.09-0.81%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -21.82% | 20.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -21.82% | 20.61% | |||
| Cost of Revenue | -25.59% | 30.95% | |||
| Gross Profit | -20.61% | 17.65% | |||
| SG&A Expenses | -11.61% | 9.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.31% | 15.72% | |||
| Operating Income | -35.92% | 35.26% | |||
| Income Before Tax | -32.91% | 33.51% | |||
| Income Tax Expenses | -50.30% | 33.52% | |||
| Earnings from Continuing Operations | -26.64% | 33.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -26.64% | 33.51% | |||
| EBIT | -35.92% | 35.26% | |||
| EBITDA | -34.70% | 37.60% | |||
| EPS Basic | -26.60% | 33.41% | |||
| Normalized Basic EPS | -32.90% | 33.48% | |||
| EPS Diluted | -26.65% | 33.02% | |||
| Normalized Diluted EPS | -32.99% | 33.46% | |||
| Average Basic Shares Outstanding | 0.02% | 0.05% | |||
| Average Diluted Shares Outstanding | 0.05% | 0.04% | |||
| Dividend Per Share | -1.10% | 0.55% | |||
| Payout Ratio | 0.35% | -0.25% | |||